Factor XIII

Factor XIII crosslinks fibrin

coagulation factor XIII, A1 polypeptide
Identifiers
Symbol	F13A1
Alt. Symbols	F13A
Entrez	2162
HUGO	3531
OMIM	134570
RefSeq	NM_000129
UniProt	P00488
Other data
Locus	Chr. 6 p24.2-p23

coagulation factor XIII, B polypeptide
Identifiers
Symbol	F13B
Entrez	2165
HUGO	3534
OMIM	134580
RefSeq	NM_001994
UniProt	P05160
Other data
Locus	Chr. 1 q31-q32.1

WikiDoc Resources for Factor XIII
Articles
Most recent articles on Factor XIII Most cited articles on Factor XIII Review articles on Factor XIII Articles on Factor XIII in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Factor XIII Images of Factor XIII Photos of Factor XIII Podcasts & MP3s on Factor XIII Videos on Factor XIII
Evidence Based Medicine
Cochrane Collaboration on Factor XIII Bandolier on Factor XIII TRIP on Factor XIII
Clinical Trials
Ongoing Trials on Factor XIII at Clinical Trials.gov Trial results on Factor XIII Clinical Trials on Factor XIII at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Factor XIII NICE Guidance on Factor XIII NHS PRODIGY Guidance FDA on Factor XIII CDC on Factor XIII
Books
Books on Factor XIII
News
Factor XIII in the news Be alerted to news on Factor XIII News trends on Factor XIII
Commentary
Blogs on Factor XIII
Definitions
Definitions of Factor XIII
Patient Resources / Community
Patient resources on Factor XIII Discussion groups on Factor XIII Patient Handouts on Factor XIII Directions to Hospitals Treating Factor XIII Risk calculators and risk factors for Factor XIII
Healthcare Provider Resources
Symptoms of Factor XIII Causes & Risk Factors for Factor XIII Diagnostic studies for Factor XIII Treatment of Factor XIII
Continuing Medical Education (CME)
CME Programs on Factor XIII
International
Factor XIII en Espanol Factor XIII en Francais
Business
Factor XIII in the Marketplace Patents on Factor XIII
Experimental / Informatics
List of terms related to Factor XIII

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Factor XIII or fibrin stabilizing factor is an enzyme (EC 2.3.2.13) of the blood coagulation system that crosslinks fibrin. When thrombin has converted fibrinogen to fibrin, the latter forms a proteinaceous network in which every E-unit is crosslinked to only one D-unit. Factor XIII is activated by thrombin into factor XIIIa; its activation into Factor XIIIa requires calcium as a cofactor.

FXIII is known also as Laki-Lorand factor, after the scientists who first proposed its existence in 1948. A 2005 conference recommended standardization of nomenclature.

Genetics

Zymogene factor XIII is a 320000 M_r glycoprotein tetramer consisting of twice two subunits (2 A and 2 B), the genes for which are on different chromosomes:

• A subunit (6p25-p24). The transglutaminase part; this adds an alkyl group to the nitrogen on a glutamine residue, which binds in turn with a lysine on the other chain. The molecular weight of the A chain is approximately 83000.
• B subunit (1q31-q32.1). This has no clear enzymatic activity, and may serve as a carrier for the A subunit. The molecular weight of the B chain is approximately 76500.

Physiology

Typical concentrations of FXIII in plasma is 10 μg/ml (2A2B heterodimer), while the concentration of free B chain is 22 μg/ml. FXIII has a long half life, ranging from 5-9 days. It is present in plasma, platelets, and monocytes, as well as macrophages and bone marrow precursors of these cell types.

A clot that has not been stabilized by FXIIIa is soluble in 5 mol/L urea, while a stabilized clot is resistant to this phenomenon.

Diagnostic use

Factor XIII levels are not measured routinely, but may be considered in patients with an unexplained bleeding tendency. As the enzyme is quite specific for monocytes and macrophages, determination of the presence of factor XIII may be used to identify and classify malignant diseases involving these cells.

See also

• Factor XIII deficiency
• D-dimer